drugs, | press-releases,policy-forums,update-magazine,whitepapers, | Knowledge Center

Tobacco Control Act Substantial Equivalence Rebuttal Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on April 2013 by Michael Levin-Epstein

In the Aftermath of Parens Patriae: Can Private Copycats Still Sue?

Posted on April 2013 by James M. Beck, Counsel, Reed Smith LLP

This issue of our Policy Forum (Volume 3, Number 8, April 24, 2013) — In the Aftermath of Parens Patriae: Can Private Copycats Still Sue? — explains that pharma...read more

Prohibition on Use of Chimpanzees for Biomedical Research Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on March 2013 by Michael Levin-Epstein

Out on a Limb: How Will the Prohibition of Biomedical Research Using Chimpanzees Harm Public Health?

Posted on March 2013 by Fern P. O’Brian, Partner, and Barbara A. Lum, Associate, Thompson Hine, LLP

In this issue of our Policy Forum (Volume 3, Number 5, March 13, 2013) – Out on a Limb: How Will the Prohibition of Biomedical Research Using Chimpanzees Harm Public Health? – examines ...read more

What is the Best Way for Manufacturers and Physicians to Apply Sunscreen to Avoid Being Burned by the Final Sunshine Act Regulations?

Posted on February 2013 by Abraham Gitterman, Research Associate, Rockpoint, Inc.

This issue of Policy Forum (Volume 3, Number 4, February 27, 2013) explains the requirements under the Patient Protection and Affordable Health Care Act’s Physician Payment Sunshine...read more

Implementing Physician Payment Sunshine Act Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on February 2013 by Michael Levin-Epstein

Consequences of Landmark Second Circuit Decision in United States v. Caronia Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on February 2013 by Michael Levin-Epstein

What Does the Second Circuit’s Recent Decision in United States v. Caronia Not Say?

Posted on February 2013 by Geoffrey R. Kaiser, Founder, Kaiser Law Firm, PLLC; Former Chief of Healthcare Fraud Prosecutions, United States Attorney’s Office for the Eastern District of New York

This issue of Policy Forum (Volume 3, Number 3, February 13, 2013) — "What Does the Second Circuit’s Recent Decision in United States v. Caronia Not Say?" — deconstructs the landm...read more

DEA Guidance on Suspicious Drug Orders Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on January 2013 by Michael Levin-Epstein

Should DEA Provide Guidance and Conduct Rulemaking on Suspicious Orders to Ensure a Balanced Approach to Reduce Abuse and Ensure Availability of Needed Medicine?

Posted on January 2013 by Larry K. Houck, Of Counsel, Hyman, Phelps & McNamara, P.C.

This issue of Policy Forum (Volume 3, Number 2, January 23, 2013) – “Should DEA Provide Guidance and Conduct Rulemaking on Suspicious Orders to Ensure a Balanced Approach to Reduce...read more

FDLI

Tobacco Control Act Substantial Equivalence Rebuttal Is Focus of New FDLI Food and Drug Law Policy Forum

In the Aftermath of Parens Patriae: Can Private Copycats Still Sue?

Prohibition on Use of Chimpanzees for Biomedical Research Is Focus of New FDLI Food and Drug Law Policy Forum

Out on a Limb: How Will the Prohibition of Biomedical Research Using Chimpanzees Harm Public Health?

What is the Best Way for Manufacturers and Physicians to Apply Sunscreen to Avoid Being Burned by the Final Sunshine Act Regulations?

Implementing Physician Payment Sunshine Act Is Focus of New FDLI Food and Drug Law Policy Forum

Consequences of Landmark Second Circuit Decision in United States v. Caronia Is Focus of New FDLI Food and Drug Law Policy Forum

What Does the Second Circuit’s Recent Decision in United States v. Caronia Not Say?

DEA Guidance on Suspicious Drug Orders Is Focus of New FDLI Food and Drug Law Policy Forum

Should DEA Provide Guidance and Conduct Rulemaking on Suspicious Orders to Ensure a Balanced Approach to Reduce Abuse and Ensure Availability of Needed Medicine?

Resources

Products & Services